ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
10 2022
Historique:
received: 18 07 2022
revised: 16 08 2022
accepted: 22 08 2022
pubmed: 6 9 2022
medline: 28 9 2022
entrez: 5 9 2022
Statut: ppublish

Résumé

N-glycosylation and disulfide bond formation are two essential steps in protein folding that occur in the endoplasmic reticulum (ER) and reciprocally influence each other. Here, to analyze crosstalk between N-glycosylation and oxidation, we investigated how the protein disulfide oxidase ERO1-alpha affects glycosylation of the angiogenic VEGF

Identifiants

pubmed: 36063727
pii: S2213-2317(22)00227-0
doi: 10.1016/j.redox.2022.102455
pmc: PMC9463388
pii:
doi:

Substances chimiques

Disulfides 0
Lectins 0
Membrane Glycoproteins 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
Thioredoxins 52500-60-4
ERO1A protein, human EC 1.-
Oxidoreductases EC 1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102455

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflicting interests.

Auteurs

Ersilia Varone (E)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Alexander Chernorudskiy (A)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Alessandro Cherubini (A)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Angela Cattaneo (A)

Proteomics/MS Facility, Cogentech SRL Benefit Corporation, Milan, Italy.

Angela Bachi (A)

IFOM-FIRC Institute of Molecular Oncology, Milan, Italy.

Stefano Fumagalli (S)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Gizem Erol (G)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Marco Gobbi (M)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Michael J Lenardo (MJ)

Molecular Development of the Immune System Section, Laboratory of Immune System Biology, And Clinical Genomics Program, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Nica Borgese (N)

CNR Neuroscience Institute, c/o University of Milano Bicocca, Vedano al Lambro (MB), Italy.

Ester Zito (E)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Biomolecular Sciences, University of Urbino Carlo Bo, Italy. Electronic address: ester.zito@marionegri.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH